These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17921187)
1. Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases. Zielinska A; Lichti CF; Bratton S; Mitchell NC; Gallus-Zawada A; Le VH; Finel M; Miller GP; Radominska-Pandya A; Moran JH J Pharmacol Exp Ther; 2008 Jan; 324(1):139-48. PubMed ID: 17921187 [TBL] [Abstract][Full Text] [Related]
2. Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases. Bratton SM; Mosher CM; Khallouki F; Finel M; Court MH; Moran JH; Radominska-Pandya A J Pharmacol Exp Ther; 2012 Jan; 340(1):46-55. PubMed ID: 21972237 [TBL] [Abstract][Full Text] [Related]
3. Regioselectivity significantly impacts microsomal glucuronidation efficiency of R/S-6, 7-, and 8-hydroxywarfarin. Kim SY; Jones DR; Kang JY; Yun CH; Miller GP Xenobiotica; 2019 Apr; 49(4):397-403. PubMed ID: 29543105 [TBL] [Abstract][Full Text] [Related]
4. Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin. Jones DR; Kim SY; Guderyon M; Yun CH; Moran JH; Miller GP Chem Res Toxicol; 2010 May; 23(5):939-45. PubMed ID: 20429590 [TBL] [Abstract][Full Text] [Related]
5. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine. Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623 [TBL] [Abstract][Full Text] [Related]
6. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Watanabe Y; Nakajima M; Yokoi T Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820 [TBL] [Abstract][Full Text] [Related]
7. Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites. Pugh CP; Pouncey DL; Hartman JH; Nshimiyimana R; Desrochers LP; Goodwin TE; Boysen G; Miller GP Arch Biochem Biophys; 2014 Dec; 564():244-53. PubMed ID: 25447818 [TBL] [Abstract][Full Text] [Related]
8. Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin. Miller GP; Lichti CF; Zielinska AK; Mazur A; Bratton SM; Gallus-Zawada A; Finel M; Moran JH; Radominska-Pandya A Drug Metab Dispos; 2008 Nov; 36(11):2211-8. PubMed ID: 18725508 [TBL] [Abstract][Full Text] [Related]
9. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine. Sun H; Zhang T; Wu Z; Wu B J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417 [TBL] [Abstract][Full Text] [Related]
10. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8. Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR Eur J Drug Metab Pharmacokinet; 2006; 31(4):299-309. PubMed ID: 17315542 [TBL] [Abstract][Full Text] [Related]
11. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs. Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190 [TBL] [Abstract][Full Text] [Related]
12. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261 [TBL] [Abstract][Full Text] [Related]
13. Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism. Jones DR; Moran JH; Miller GP Drug Metab Rev; 2010 Feb; 42(1):55-61. PubMed ID: 19788348 [TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Kuuranne T; Kurkela M; Thevis M; Schänzer W; Finel M; Kostiainen R Drug Metab Dispos; 2003 Sep; 31(9):1117-24. PubMed ID: 12920167 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7. Seo KA; Bae SK; Choi YK; Choi CS; Liu KH; Shin JG Drug Metab Dispos; 2010 Nov; 38(11):2007-13. PubMed ID: 20713656 [TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms. Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045 [TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347 [TBL] [Abstract][Full Text] [Related]
18. Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms. Nakajima M; Tanaka E; Kobayashi T; Ohashi N; Kume T; Yokoi T Drug Metab Dispos; 2002 Jun; 30(6):636-42. PubMed ID: 12019188 [TBL] [Abstract][Full Text] [Related]
19. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes. Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132 [TBL] [Abstract][Full Text] [Related]
20. Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man. Tougou K; Gotou H; Ohno Y; Nakamura A Xenobiotica; 2004 May; 34(5):449-61. PubMed ID: 15370961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]